Clinical Trials Browser

Lymphoproliferative Disorders × etoposide phosphate × 90 days × Clear all

NCT06954805 2026-05-27

Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

Phase 2 Recruiting

Lymphoma, Lymphoproliferative Disorders, Lymphoma, B-Cell